Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
GDC-0941
Cat No.
CEI-0125
Description
GDC-0941 can inhibit p110-alpha with IC50 of less than 10 nM.
CAS No.
957054-30-7
Molecular Weight
513.64
Purity
>99%
Storage
2 years at -20centigrade Powder
Targets
p110-alpha
Molecular Formula
C23H27N7O3S2
Chemical Name
2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidine
Solubility
DMSO 44 mg/mL Water
In vitro
GDC-0941, a class I selective PI3K inhibitor, can inhibit p110-alpha with IC50 of less than 10 nM. GDC-0941 showed a high efficacy of antitumor activity in two gefitinib-resistant non-small cell lung cancer (NSCLC) cell lines, A549 and H460,as H460 cells with activating mutations of PIK3CA were relatively more sensitive to GDC-0941 than A549 cells with wild-type PIK3CA.
In vivo
In GIST xenograft models, GDC-0941 causes tumor growth stabilization, inhibiting tumor cell proliferation, but did not induce apoptosis. Combination of DOX with the specific PI3K inhibitor GDC-0941 can lead to caspase 3 activation in xenografts of sarcoma cells.
Download
Download Datasheet